We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clinigen Group Plc | LSE:CLIN | London | Ordinary Share | GB00B89J2419 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 925.00 | 924.50 | 925.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/4/2015 12:25 | Video interview with CEO Peter George Peter George, chief executive of Clinigen (LON:CLIN), says the £225mln acquisition of competitor Idis gives it access to the US$2.2bln ethical unlicensed medicine market. Synergy savings of £2.5mln have been identified in the deal which makes the specialty pharma company the global leader in unlicensed medicines. George tells Proactive Investors profit will be driven through the gross profit line much faster than synergy savings. “This is about a growth plan not a cost savings plan. We want to hit the ground running and take the market by storm.” The deal achieves the second of Clinigen’s four strategic goals which include becoming global leader in both clinical trials supply and unlicensed medicines. George says Clinigen wants to grow its portfolio from five to ten products and improve its global footprint by looking at the Southern hemisphere. | proactivest | |
24/4/2015 10:59 | Slogweep - just a small correction. new shares placed is 27m; existing shares = 125m. So percentage new raised = 22%. But your point is still valid. | ramridge | |
24/4/2015 10:30 | very tempted to add,just wondering if we will have a pull back | gucci | |
24/4/2015 10:25 | I did a back of the envelope and seems to be circa 9% EBITDA per share enhancing in 2015 (I ignored both synergies and higher interest costs). Looks very good. | hutch_pod | |
24/4/2015 10:05 | Glad I didn't sell down any of these to part-fund my Opay rights! | lomax99 | |
24/4/2015 09:45 | well done AISHAH | gucci | |
24/4/2015 09:45 | Numis, BUY - ups target to 860p | aishah | |
24/4/2015 09:05 | That's a whopper! Take a bow SCSW - I bought in at £1.83p in 2012. Run your winners imo. | aishah | |
24/4/2015 08:35 | im sure Jim Slatter will be commenting in his next update in Telegraph soon | gucci | |
24/4/2015 08:31 | Share capital increase by 50% in a discounted placing - shareholders shut out again! Why not have a rights issue - It should be compulsory to have a rights issue if the new shares issued exceed 10% of those already in issue, with a moratorium on further issues within 12 months. | slogsweep | |
24/4/2015 08:28 | Damn, I was waiting for 500p to increase. Fat chance now - I hate it when this happens. apad | apad | |
24/4/2015 08:26 | Have done -- this is adding massive potential! | ddav | |
24/4/2015 08:26 | Looks like a great deal. Didnt get filled this morning so topup on next pullback. | phowdo | |
24/4/2015 08:16 | perfect time to add imo | gucci | |
24/4/2015 07:56 | That looks a very interesting acquisition: will become the market leader Immediately earnings enhancing significantly earnings enhancing in its full year further earnings enhancing in future years. | cfro | |
15/4/2015 13:25 | Not bosom-buddies i hope though, gucci! :-/ | cfro | |
15/4/2015 12:00 | :-) yes we are buddies | gucci | |
15/4/2015 11:19 | Hi gucci, we seem to be bumping into each alot lately. :-) Nice steady gains here over last few days. Happy to be patient and await drug acquisition news. Cant be too far away now i wouldn't have thought. | cfro | |
15/4/2015 10:45 | good looking chart | gucci | |
27/3/2015 16:08 | Looking to break out | gucci | |
27/3/2015 15:02 | To view Clinigen's presentation from last night's Proactive Investors One2One Investor Forum, click on the following link: | aim_trader | |
26/3/2015 11:45 | A reminder that Shaun Chilton, COO will be presenting tonight at the Chesterfield, Mayfair. To register click here: | aim_trader | |
20/3/2015 10:01 | lets hope for new highs soon | gucci | |
20/3/2015 09:58 | Sp flying back up now.... Just shows how quickly this can move in either direction. Quite a volatile share at times. | cfro | |
20/3/2015 08:33 | Clin Clinigen Broker Views........... Clinigen Group broker views Date Broker Recommendation Price Old target price New target price Notes 11 Mar N+1 Singer Buy 527.00 590.00 590.00 Retains 03 Mar Investec Hold 527.00 546.00 - Under Review 03 Mar Numis Buy 527.00 650.00 770.00 Reiterates | mike740 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions